Oregon Cancer
News and information for cancer services throughout Oregon.
-
Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma
New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.
-
New studies test immunotherapy to boost breast cancer treatment and prevent return
Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.
-
Attend a free virtual symposium on melanoma, Oct. 25
Providence Cancer Institute in partnership with AIM at Melanoma present a free online event designed to educate and empower patients and care partners affected by melanoma.
-
Prostate cancer study includes a tumor test to personalize treatment
A new study approach reflects a deeper understanding of cancer at the molecular level and marks a shift away from one-size-fits-all treatments.
-
Meet physician scientist, Dr. Allie Grossmann
Dr. Allie Grossmann’s new lab at Earle A. Chiles Research Institute is focused on understanding how tumors communicate with their environment, grow, survive and spread.
-
Dr. Walter Urba announces retirement from Providence
Dr. Walter Urba, a pioneer and key figure in the development of immunotherapy, will retire from Providence Cancer Institute at the end of year.
-
Dr. Bernard Fox honored for his lifetime contributions to cancer research
Prominent cancer scientist Dr. Bernard Fox recognized for his work to advance the field of cancer immunotherapy through increasing public understanding, awareness and research efforts.
-
Can these new studies offer hope for people with lung and head and neck cancers?
A new medication may help people with KRAS G12C-mutant non-small cell lung cancer. Read about the study and a trial evaluating an immunotherapy for treating head and neck squamous cell carcinoma.
-
Cancer survivor speaks with doctor he credits for saving his life
Cancer survivor Mark Williams chats with Dr. Brendan Curti about
-
2024 Hood to Coast Relay: Providence team captains tell us why they run
What motivates the co-captains of the FINISHCANCER caregiver team to commit their time to running this remarkable relay? Read what they say about preparing for the race and what inspires them to run.
-
Promising advances in treating TNBC: Two studies offer hope
Although chemotherapy is the cornerstone treatment for triple negative breast cancer, survival outcomes remain disappointing. Two studies could help improve treatment options.
-
Targeting cancer cells: Two studies take different approaches
A study designed to treat recurrent epithelial ovarian cancer looks at an antibody drug conjugate, and a second study for people with advanced breast cancer evaluates a drug that degrades estrogen rec
-
The evolution of cancer immunotherapy: Dr. Urba shares his insights
Providence Cancer Institute chief medical officer Walter J. Urba, M.D., Ph.D. talks about the evolution of immunotherapy in the past three decades and his vision for its future.
-
Cancer survivorship: A guide to living with and beyond cancer
June is National Cancer Survivor Month, but we honor people with cancer, no matter where they are on their journey, every day of the year. Find out about the survivorship program at Providence Cancer
-
Radiation oncologist discusses MRI-guided radiation therapy for pancreatic cancer
Providence Cancer Institute presented a free virtual education event about MRI-guided radiation therapy and how it is used to treat pancreatic cancer.
-
Providence researchers contribute study findings at ASCO 2024 meeting, May 31- June 3
The annual meeting of cancer experts is a platform to collaborate and accelerate cancer research findings into clinical applications.
-
With the potential to transform cancer diagnostics, Providence contributes to innovative AI-powered digital pathology model
A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model has been published in Nature.
-
2023 research report highlights breadth and impact of research at Providence
Providence researchers conducted over 2400 studies in 2023, according to the 2023 Providence Research Network Annual Report
-
Cancer studies seek to harness the power of the immune system
Explore three innovative studies targeting uveal melanoma, melanoma and head and neck squamous cell carcinoma. Learn why these studies offer hope for more effective cancer treatments.
-
Celebrating World Immunology Day
Providence Cancer Institute researcher shares her journey to immunology and the advice she has for those seeking a career in cancer research.
- Loading More...